Blog Archives

ORAL PRESENTATION: Initial results from a Phase 1 clinical study with an investigational next-generation anti-BCMA CAR T therapy

ORAL PRESENTATION: EVOLVE Trial: Results from a Phase 1/2 study of an investigational anti-BCMA CAR T Cell Therapy for Relapse/Refractory Multiple Myeloma

ORAL PRESENTATION: AUGMENT Trial: A Phase 3 Study in Patients with Relapse/Refractory Indolent Non-Hodgkin's Lymphoma

ORAL PRESENTATION: BELIEVE Trial: Results of a Phase 3 study in Adult Beta-Thalassemia Patients

ORAL PRESENTATION: TRANSCEND Trial: Results in patients with relapsed/refractory CLL treated with and investigational CD-19-directed CAR T cell therapy

PLENARY SESSION: MEDALIST Trial: A Phase 3 Study in Patients with Very Low-, Low-, or Intermediate-Risk MDS